The Value of and Challenges for Cholera Vaccines in Africa
Open Access
- 7 October 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (suppl 1) , S8-S14
Abstract
The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for >20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.Keywords
This publication has 35 references indexed in Scilit:
- Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011Emerging Infectious Diseases, 2011
- Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled TrialPLOS Neglected Tropical Diseases, 2011
- Climate Variability and the Outbreaks of Cholera in Zanzibar, East Africa: A Time Series AnalysisThe American Journal of Tropical Medicine and Hygiene, 2011
- The Case for Reactive Mass Oral Cholera VaccinationsPLOS Neglected Tropical Diseases, 2011
- Vaccination Strategies to Combat an Infectious Globe: Oral Cholera VaccinesJournal of Global Infectious Diseases, 2011
- Environmental signatures associated with cholera epidemicsProceedings of the National Academy of Sciences, 2008
- Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophageProceedings of the National Academy of Sciences, 2007
- Prediction of epidemic cholera due toVibrio choleraeO1 in children younger than 10 years using climate data in BangladeshEpidemiology and Infection, 2007
- The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy VolunteersInfection and Immunity, 2005
- Effects of Global Climate on Infectious Disease: the Cholera ModelClinical Microbiology Reviews, 2002